Susquehanna International Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-50,200
| Closed | -$472K | – | 12074 |
|
|
2020
Q3 | $472K | Sell |
50,200
-83,700
| -63% | -$796K | ﹤0.01% | 7808 |
|
|
2020
Q2 | $1.02M | Buy |
133,900
+116,100
| +652% | +$888K | ﹤0.01% | 5865 |
|
|
2020
Q1 | $110K | Sell |
17,800
-36,000
| -67% | -$317K | ﹤0.01% | 9259 |
|
|
2019
Q4 | $655K | Sell |
53,800
-72,300
| -57% | -$790K | ﹤0.01% | 6407 |
|
|
2019
Q3 | $1.46M | Sell |
126,100
-22,800
| -15% | -$240K | ﹤0.01% | 4888 |
|
|
2019
Q2 | $1.49M | Buy |
148,900
+53,900
| +57% | +$581K | ﹤0.01% | 4788 |
|
|
2019
Q1 | $1.22M | Buy |
95,000
+77,200
| +434% | +$1.15M | ﹤0.01% | 4630 |
|
|
2018
Q4 | $270K | Sell |
17,800
-42,500
| -70% | -$810K | ﹤0.01% | 7194 |
|
|
2018
Q3 | $1.21M | Sell |
60,300
-45,200
| -43% | -$1.03M | ﹤0.01% | 4869 |
|
|
2018
Q2 | $2.06M | Sell |
105,500
-215,900
| -67% | -$4.78M | ﹤0.01% | 3969 |
|
|
2018
Q1 | $6.48M | Buy |
321,400
+131,700
| +69% | +$2.23M | ﹤0.01% | 2218 |
|
|
2017
Q4 | $2.51M | Buy |
189,700
+7,300
| +4% | +$110K | ﹤0.01% | 3515 |
|
|
2017
Q3 | $3.37M | Buy |
182,400
+100
| +0.1% | +$1.86K | ﹤0.01% | 3058 |
|
|
2017
Q2 | $3.35M | Buy |
182,300
+56,100
| +44% | +$1.11M | ﹤0.01% | 2978 |
|
|
2017
Q1 | $2.85M | Buy |
126,200
+82,300
| +187% | +$1.97M | ﹤0.01% | 3118 |
|
|
2016
Q4 | $1.53M | Sell |
43,900
-180,800
| -80% | -$5.4M | ﹤0.01% | 4626 |
|
|
2016
Q3 | $5.51M | Buy |
224,700
+203,200
| +945% | +$5.08M | ﹤0.01% | 2127 |
|
|
2016
Q2 | $514K | Buy |
+21,500
| New | +$493K | ﹤0.01% | 6077 |
|
|
2014
Q4 | – | Sell |
-18,100
| Closed | -$578K | – | 10287 |
|
|
2014
Q3 | $578K | Buy |
+18,100
| New | +$386K | ﹤0.01% | 6953 |
|
|
2014
Q2 | – | Sell |
-19,600
| Closed | -$379K | – | 10250 |
|
|
2014
Q1 | $379K | Buy |
+19,600
| New | +$416K | ﹤0.01% | 7212 |
|
|
2013
Q4 | – | Sell |
-18,000
| Closed | -$387K | – | 9489 |
|
|
2013
Q3 | $387K | Buy |
+18,000
| New | +$425K | ﹤0.01% | 6814 |
|
Susquehanna International Group's AMAG Position: Q2 2020 in Review
Susquehanna International Group sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 29,134 shares — an estimated $223K sold.
Susquehanna International Group first reported a position in AMAG in Q2 2014 and held it in 16 quarters. The position peaked at $21.3M in Q2 2015. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.
- Susquehanna International Group reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 29,134 AMAG Pharmaceuticals shares in Q2 2020, an estimated $223K.
- Susquehanna International Group first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 16 quarters.
- Susquehanna International Group's AMAG Pharmaceuticals position peaked at $21.3M in Q2 2015.
- 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.